EVER Pharma Therapeutics

EVER Pharma is a fully integrated specialty pharmaceutical company headquartered in Austria, focusing on the development, production, and commercialization of products in neurology, critical care, oncology, and hormone therapy. The company is a global leader in neuroregeneration, primarily through its flagship product Cerebrolysin, used in the treatment of stroke and dementia. Additionally, EVER Pharma provides advanced solutions for Parkinson's disease, including the Dacepton brand of apomorphine and associated delivery pumps. Beyond its proprietary portfolio, the company operates high-tech GMP manufacturing facilities that specialize in complex injectables, including vials, pre-filled syringes, and cartridges. EVER Pharma serves more than 70 markets worldwide, maintaining a strong presence in both hospital and specialist retail sectors. The company's integrated approach allows it to manage the entire product lifecycle from initial R&D to sterile manufacturing and global distribution.